LCC_LYCCL
ID LCC_LYCCL Reviewed; 756 AA.
AC A0A125SXN1;
DT 07-NOV-2018, integrated into UniProtKB/Swiss-Prot.
DT 13-APR-2016, sequence version 1.
DT 25-MAY-2022, entry version 20.
DE RecName: Full=Pre-alpha-onocerin synthase LCC {ECO:0000303|PubMed:26663356};
DE EC=5.4.99.65 {ECO:0000269|PubMed:26663356};
GN Name=LCC {ECO:0000303|PubMed:26663356};
OS Lycopodium clavatum (Stag's-horn clubmoss).
OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC Lycopodiopsida; Lycopodiales; Lycopodiaceae; Lycopodioideae; Lycopodium.
OX NCBI_TaxID=3252;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX PubMed=26663356; DOI=10.1002/cbic.201500663;
RA Araki T., Saga Y., Marugami M., Otaka J., Araya H., Saito K., Yamazaki M.,
RA Suzuki H., Kushiro T.;
RT "Onocerin biosynthesis requires two highly dedicated triterpene cyclases in
RT a fern Lycopodium clavatum.";
RL ChemBioChem 17:288-290(2016).
CC -!- FUNCTION: Oxidosqualene cyclase involved in the biosynthesis of alpha-
CC onocerin, a triterpenoid characterized by a symmetrical structure due
CC to cyclizations at both termini of dioxidosqualene that inhibits
CC acetylcholinesterase. Catalyzes the first half of the cyclization,
CC exclusively from dioxidosqualene. {ECO:0000269|PubMed:26663356}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=(3S,22S)-2,3:22,23-diepoxy-2,3,22,23-tetrahydrosqualene = pre-
CC alpha-onocerin; Xref=Rhea:RHEA:54664, ChEBI:CHEBI:138305,
CC ChEBI:CHEBI:138307; EC=5.4.99.65;
CC Evidence={ECO:0000269|PubMed:26663356};
CC -!- PATHWAY: Secondary metabolite biosynthesis; terpenoid biosynthesis.
CC {ECO:0000269|PubMed:26663356}.
CC -!- SIMILARITY: Belongs to the terpene cyclase/mutase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; LC053635; BAU46471.1; -; mRNA.
DR AlphaFoldDB; A0A125SXN1; -.
DR SMR; A0A125SXN1; -.
DR KEGG; ag:BAU46471; -.
DR BRENDA; 5.4.99.65; 3106.
DR UniPathway; UPA00213; -.
DR GO; GO:0005811; C:lipid droplet; IEA:InterPro.
DR GO; GO:0016866; F:intramolecular transferase activity; IEA:InterPro.
DR GO; GO:0016104; P:triterpenoid biosynthetic process; IDA:UniProtKB.
DR CDD; cd02892; SQCY_1; 1.
DR InterPro; IPR032696; SQ_cyclase_C.
DR InterPro; IPR032697; SQ_cyclase_N.
DR InterPro; IPR018333; Squalene_cyclase.
DR InterPro; IPR002365; Terpene_synthase_CS.
DR InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR PANTHER; PTHR11764; PTHR11764; 1.
DR Pfam; PF13243; SQHop_cyclase_C; 1.
DR Pfam; PF13249; SQHop_cyclase_N; 1.
DR SUPFAM; SSF48239; SSF48239; 2.
DR TIGRFAMs; TIGR01787; squalene_cyclas; 1.
DR PROSITE; PS01074; TERPENE_SYNTHASES; 1.
PE 1: Evidence at protein level;
KW Isomerase; Repeat.
FT CHAIN 1..756
FT /note="Pre-alpha-onocerin synthase LCC"
FT /id="PRO_0000445704"
FT REPEAT 96..138
FT /note="PFTB 1"
FT /evidence="ECO:0000255"
FT REPEAT 146..187
FT /note="PFTB 2"
FT /evidence="ECO:0000255"
FT REPEAT 438..491
FT /note="PFTB 3"
FT /evidence="ECO:0000255"
FT REPEAT 512..554
FT /note="PFTB 4"
FT /evidence="ECO:0000255"
FT REPEAT 589..629
FT /note="PFTB 5"
FT /evidence="ECO:0000255"
FT REPEAT 638..679
FT /note="PFTB 6"
FT /evidence="ECO:0000255"
FT REPEAT 700..747
FT /note="PFTB 7"
FT /evidence="ECO:0000255"
FT ACT_SITE 483
FT /note="Proton donor"
FT /evidence="ECO:0000250|UniProtKB:P48449"
FT SITE 416
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000250|UniProtKB:P48449"
FT SITE 610
FT /note="Transition state stabilizer"
FT /evidence="ECO:0000250|UniProtKB:P48449"
SQ SEQUENCE 756 AA; 86189 MW; B40C6F86045D51BA CRC64;
MWKLKIAEGS PGLDTLNDHV GRQIWCYEKD AGTPEEHAEV EEARAKFTEQ RHEQRQSADI
LMKLQLLKEN SFSPLPTQPK VDRFEDITED AVQTTLRRAL RFFAAIQAHD GHWPGDHAGL
MFLTPCLVIC LYVTGALNTV LSEAHRQEMR RYLYNHQNKD GGWGLNIESH STMFCTVFSY
VTLRLLEEGP HDGDEGAMES ARLWILDHGG AIAIPSWGKF WLAVLGVFEW SGVHPMPPEI
WFLPHFLPIH PGQMNIHGKL ILLPMTYIYG RQFVGPITSL VKALRGEIFS THYNTIDWQE
ARTMCAKEDR YYSTPFVQDL AFTFAKQCTE PLLRSWPGSL VRKKALERVI KWIHTEDKNF
RYVGIGPLSK VSVMLCCWIE DPNSEAFKRH LLRVHDYLWL AEDGMKMQGY NGCQMWETVL
GTQAVLSARM HDECNSMLRK AEDYISKTQI QEDGNLDTKL WYHKISKGGW PHSTRDHGWP
ISDCSAEGLK VALALADLPW AMTGSQISEE NLFDCVNVIL SLQNPDGGFS AFELKRAYPW
AEKLLQSETF GDITIDYSWV ECSSSCIQAL VAFKKKYTTH RKEEICRAIN RACRFIESIQ
RKDGSWYGYW AVCFTYGAWF GITGLVAAGK SFHESEAIRR ACDFLLSKQL PSGGWGESYL
SSENEEYTHL KHGRAHVVHT AWSLLALLAS GQAERDPVPL HRAATILINS QLENGDYPQQ
EIVGAIHKTC MTTYTLFCNI FAIQALGEYR QKIFHS